Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date14 Apr 2020 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1994 |
100 Clinical Results associated with Heilongjiang Linbao Pharmaceutical Co., Ltd
0 Patents (Medical) associated with Heilongjiang Linbao Pharmaceutical Co., Ltd
100 Deals associated with Heilongjiang Linbao Pharmaceutical Co., Ltd
100 Translational Medicine associated with Heilongjiang Linbao Pharmaceutical Co., Ltd